MAPK1 and colorectal cancer: Our study further demonstrates that GSK-650394 is involved in the generation of pre-metastatic niches in the colorectal cancer livers by inhibiting IR-infiltrating neutrophil SGK1/ERK/NETs signaling, thereby attenuating CRLM progression after IR.